JXHL1500238 | 多替阿巴拉米片 | abacavir sulfate;dolutegravir sodium;lamivudine | Tablet | Chemical Drugs | Import Drug Application | 2015-09-18 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2016-09-26 | view |
JYHB2100129 | 多替阿巴拉米片 | abacavir sulfate;dolutegravir sodium;lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2021-02-06 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-05 | view |
JYHB2001114 | 多替阿巴拉米片 | abacavir sulfate;dolutegravir sodium;lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2020-06-28 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Filed | 2020-06-30 | view |
JYHB1900197 | 多替阿巴拉米片 | abacavir sulfate;dolutegravir sodium;lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2019-03-11 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2019-09-10 | view |
JXHS1600077 | 多替阿巴拉米片 | abacavir sulfate;dolutegravir sodium;lamivudine | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2017-01-20 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2017-08-01 | view |
JYHB2101558 | 多替阿巴拉米片 | abacavir sulfate;dolutegravir sodium;lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2021-11-26 | | | | | view |
JYHZ2100751 | 多替阿巴拉米片 | abacavir sulfate;dolutegravir sodium;lamivudine | Tablet | Chemical Drugs | License Renew | 2022-01-04 | | | | | view |
JYHB2400146 | 多替阿巴拉米片 | abacavir sulfate;dolutegravir sodium;lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2024-04-03 | | | | | view |
JYHB2101452 | 多替阿巴拉米片 | abacavir sulfate;dolutegravir sodium;lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2021-10-11 | | | | | view |
JYHB2300628 | 多替阿巴拉米片 | abacavir sulfate;dolutegravir sodium;lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2023-11-03 | | | | | view |
JYHB2200123 | 多替阿巴拉米片 | abacavir sulfate;dolutegravir sodium;lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2022-03-07 | | | | | view |
JYHB2300326 | 多替阿巴拉米片 | abacavir sulfate;dolutegravir sodium;lamivudine | Tablet | Chemical Drugs | Supplementary Application | 2023-06-01 | | | | | view |